Renergen advised on capital raising and ASX-listing
A cross-border team from Norton Rose Fulbright has advised Renergen Limited on both its capital raising and listing on the Australian Stock Exchange.
Firm: Norton Rose Fulbright (Renergen Limited)
Deal: Renergen Limited has completed a capital raising and listed on the ASX, following its listing on the Johannesburg stock exchange AltX.
Area: Finance, corporate
Key players: Melbourne-based Norton Rose Fulbright partner Jeremy Wickens led the team, which consisted of fellow Melbournite, associate Julia Sonza. The South African team comprised Capetown-based corporate M&A director Lizel Oberholzer and associate Jarrett Whitehead.
Deal significance: Renergen is described as being a prospective producer of helium and LNG, and is listed on Johannesburg stock exchange AltX, holding a market capitalisation of approximately $90 million.
Norton Rose Fulbright represented Renergen on all corporate law aspects of its capital raise and secondary listing on the ASX, providing advice on both Australian and South African law.
According to a statement from the firm, the NRF team prepared, reviewed and advised on registration as a foreign company in Australia, the prospectus for the offer, lodgement of the prospectus with corporate regulator the Australian Securities and Investments Commission (ASIC), liaison with ASIC, the ASX listing application and liaison with ASX as well as various ancillary matters.
“We’re pleased to have been able to support Renergen from both Australia and South Africa in this important stage of its growth and development,” lead partner Jeremy Wickens added.
“Renergen will be the ASX’s first helium company and has attracted substantial international interest, including from the US government.”